CTI BioPharma: Q2 Earnings Insights



CTI BioPharma CTIC reported its Q2 earnings results on Monday, August 8, 2022 at 04:00 PM.

Here's what investors need to know about the announcement.


CTI BioPharma missed estimated earnings by 5.0%, reporting an EPS of $-0.21 versus an estimate of $-0.2.

Revenue was up $12.33 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.04 which was followed by a 14.75% increase in the share price the next day.


To track all earnings releases for CTI BioPharma visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Posted In: EarningsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!